{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:12:58Z","timestamp":1786979578774,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T00:00:00Z","timestamp":1654300800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["03Z22CN11"],"award-info":[{"award-number":["03Z22CN11"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["161L0276"],"award-info":[{"award-number":["161L0276"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["03Z22DN11"],"award-info":[{"award-number":["03Z22DN11"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["03Z22Di1"],"award-info":[{"award-number":["03Z22Di1"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RA2876\/2-2"],"award-info":[{"award-number":["RA2876\/2-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Network Molecular Medicine of the University Medicine Greifswald","award":["FOVB-2020-01"],"award-info":[{"award-number":["FOVB-2020-01"]}]},{"name":"Research Network Molecular Medicine of the University Medicine Greifswald","award":["FOVB-2021-07"],"award-info":[{"award-number":["FOVB-2021-07"]}]},{"name":"Gerhard Domagk program of the University Medicine Greifswald"},{"name":"Leducq network on vascular malformation"},{"name":"Universit\u00e4tsmedizin Greifswald"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cerebral cavernous malformations (CCM) are low-flow vascular lesions prone to cause severe hemorrhage-associated neurological complications. Pathogenic germline variants in\n                    <jats:italic>CCM1<\/jats:italic>\n                    ,\n                    <jats:italic>CCM2,<\/jats:italic>\n                    or\n                    <jats:italic>CCM3<\/jats:italic>\n                    can be identified in nearly 100% of CCM patients with a positive family history. In line with the concept that tumor-like mechanisms are involved in CCM formation and growth, we here demonstrate an abnormally increased proliferation rate of CCM3-deficient endothelial cells in co-culture with wild-type cells and in mosaic human iPSC-derived vascular organoids. The observation that NSC59984, an anticancer drug, blocked the abnormal proliferation of mutant endothelial cells further supports this intriguing concept. Fluorescence-activated cell sorting and RNA sequencing revealed that co-culture induces upregulation of proangiogenic chemokine genes in wild-type endothelial cells. Furthermore, genes known to be significantly downregulated in\n                    <jats:italic>CCM3<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    endothelial cell mono-cultures were upregulated back to normal levels in co-culture with wild-type cells. These results support the hypothesis that wild-type ECs facilitate the formation of a niche that promotes abnormal proliferation of mutant ECs. Thus, targeting the cancer-like features of CCMs is a promising new direction for drug development.\n                  <\/jats:p>","DOI":"10.1007\/s00018-022-04355-6","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T23:32:26Z","timestamp":1654299146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Contact-dependent signaling triggers tumor-like proliferation of CCM3 knockout endothelial cells in co-culture with wild-type cells"],"prefix":"10.1007","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7834-4650","authenticated-orcid":false,"given":"Matthias","family":"Rath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Schwefel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Malinverno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariush","family":"Skowronek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Leopoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin A.","family":"Pilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Biedenweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"Bekeschus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef M.","family":"Penninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Dejana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Felbor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,4]]},"reference":[{"issue":"12","key":"4355_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nrneurol.2009.177","volume":"5","author":"S Batra","year":"2009","unstructured":"Batra S, Lin D, Recinos PF, Zhang J, Rigamonti D (2009) Cavernous malformations: natural history, diagnosis and treatment. Nat Rev Neurol 5(12):659\u2013670. https:\/\/doi.org\/10.1038\/nrneurol.2009.177","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"4355_CR2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/neuros\/nyx091","volume":"80","author":"A Akers","year":"2017","unstructured":"Akers A, Al-Shahi Salman R, Awad AI, Dahlem K, Flemming K, Hart B, Kim H, Jusue-Torres I, Kondziolka D, Lee C, Morrison L, Rigamonti D, Rebeiz T, Tournier-Lasserve E, Waggoner D, Whitehead K (2017) Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the angioma alliance scientific advisory board clinical experts panel. Neurosurgery 80(5):665\u2013680. https:\/\/doi.org\/10.1093\/neuros\/nyx091","journal-title":"Neurosurgery"},{"issue":"2","key":"4355_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000486292","volume":"9","author":"S Spiegler","year":"2018","unstructured":"Spiegler S, Rath M, Paperlein C, Felbor U (2018) Cerebral cavernous malformations: an update on prevalence, molecular genetic analyses, and genetic counselling. Mol Syndromol 9(2):60\u201369. https:\/\/doi.org\/10.1159\/000486292","journal-title":"Mol Syndromol"},{"issue":"3","key":"4355_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/gim.2014.97","volume":"17","author":"R Shenkar","year":"2015","unstructured":"Shenkar R, Shi C, Rebeiz T, Stockton RA, McDonald DA, Mikati AG, Zhang L, Austin C, Akers AL, Gallione CJ, Rorrer A, Gunel M, Min W, De Souza JM, Lee C, Marchuk DA, Awad IA (2015) Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations. Genet Med 17(3):188\u2013196. https:\/\/doi.org\/10.1038\/gim.2014.97","journal-title":"Genet Med"},{"issue":"2","key":"4355_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/mgg3.60","volume":"2","author":"S Spiegler","year":"2014","unstructured":"Spiegler S, Najm J, Liu J, Gkalympoudis S, Schr\u00f6der W, Borck G, Brockmann K, Elbracht M, Fauth C, Ferbert A, Freudenberg L, Grasshoff U, Hellenbroich Y, Henn W, Hoffjan S, Huning I, Korenke GC, Kroisel PM, Kunstmann E, Mair M, Munk-Schulenburg S, Nikoubashman O, Pauli S, Rudnik-Schoneborn S, Sudholt I, Sure U, Tinschert S, Wiednig M, Zoll B, Ginsberg MH, Felbor U (2014) High mutation detection rates in cerebral cavernous malformation upon stringent inclusion criteria: one-third of probands are minors. Mol Genet Genomic Med 2(2):176\u2013185. https:\/\/doi.org\/10.1002\/mgg3.60","journal-title":"Mol Genet Genomic Med"},{"issue":"116","key":"4355_CR6","doi-asserted-by":"publisher","first-page":"ra26","DOI":"10.1126\/scisignal.2000722","volume":"3","author":"Y He","year":"2010","unstructured":"He Y, Zhang H, Yu L, Gunel M, Boggon TJ, Chen H, Min W (2010) Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development. Sci Signal 3(116):ra26. https:\/\/doi.org\/10.1126\/scisignal.2000722","journal-title":"Sci Signal"},{"issue":"3","key":"4355_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41374-018-0030-y","volume":"99","author":"HA Zeineddine","year":"2019","unstructured":"Zeineddine HA, Girard R, Saadat L, Shen L, Lightle R, Moore T, Cao Y, Hobson N, Shenkar R, Avner K, Chaudager K, Koskim\u00e4ki J, Polster SP, Fam MD, Shi C, Lopez-Ramirez MA, Tang AT, Gallione C, Kahn ML, Ginsberg M, Marchuk DA, Awad IA (2019) Phenotypic characterization of murine models of cerebral cavernous malformations. Lab Invest 99(3):319\u2013330. https:\/\/doi.org\/10.1038\/s41374-018-0030-y","journal-title":"Lab Invest"},{"issue":"9","key":"4355_CR8","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1073\/pnas.1012617108","volume":"108","author":"A Louvi","year":"2011","unstructured":"Louvi A, Chen L, Two AM, Zhang H, Min W, Gunel M (2011) Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology. Proc Natl Acad Sci U S A 108(9):3737\u20133742. https:\/\/doi.org\/10.1073\/pnas.1012617108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"4355_CR9","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1161\/ATVBAHA.120.314586","volume":"40","author":"K Wang","year":"2020","unstructured":"Wang K, Zhang H, He Y, Jiang Q, Tanaka Y, Park IH, Pober JS, Min W, Zhou HJ (2020) Mural cell-specific deletion of cerebral cavernous malformation 3 in the brain induces cerebral cavernous malformations. Arterioscler Thromb Vasc Biol 40(9):2171\u20132186. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314586","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4355_CR10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139570","author":"MA Lopez-Ramirez","year":"2021","unstructured":"Lopez-Ramirez MA, Lai CC, Soliman SI, Hale P, Pham A, Estrada EJ, McCurdy S, Girard R, Verma R, Moore T, Lightle R, Hobson N, Shenkar R, Poulsen O, Haddad GG, Daneman R, Gongol B, Sun H, Lagarrigue F, Awad IA, Ginsberg MH (2021) Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI139570","journal-title":"J Clin Invest"},{"issue":"4","key":"4355_CR11","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1161\/01.STR.0000157586.20479.fd","volume":"36","author":"J Gault","year":"2005","unstructured":"Gault J, Shenkar R, Recksiek P, Awad IA (2005) Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke 36(4):872\u2013874. https:\/\/doi.org\/10.1161\/01.STR.0000157586.20479.fd","journal-title":"Stroke"},{"issue":"1","key":"4355_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1227\/01.NEU.0000348049.81121.C1","volume":"65","author":"J Gault","year":"2009","unstructured":"Gault J, Awad IA, Recksiek P, Shenkar R, Breeze R, Handler M, Kleinschmidt-DeMasters BK (2009) Cerebral cavernous malformations: somatic mutations in vascular endothelial cells. Neurosurgery 65(1):138\u2013144. https:\/\/doi.org\/10.1227\/01.NEU.0000348049.81121.C1","journal-title":"Neurosurgery"},{"issue":"5","key":"4355_CR13","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/hmg\/ddn430","volume":"18","author":"AL Akers","year":"2009","unstructured":"Akers AL, Johnson E, Steinberg GK, Zabramski JM, Marchuk DA (2009) Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet 18(5):919\u2013930. https:\/\/doi.org\/10.1093\/hmg\/ddn430","journal-title":"Hum Mol Genet"},{"issue":"16","key":"4355_CR14","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1093\/hmg\/ddu153","volume":"23","author":"DA McDonald","year":"2014","unstructured":"McDonald DA, Shi C, Shenkar R, Gallione CJ, Akers AL, Li S, De Castro N, Berg MJ, Corcoran DL, Awad IA, Marchuk DA (2014) Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis. Hum Mol Genet 23(16):4357\u20134370. https:\/\/doi.org\/10.1093\/hmg\/ddu153","journal-title":"Hum Mol Genet"},{"issue":"5","key":"4355_CR15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/hmg\/ddn420","volume":"18","author":"A Pagenstecher","year":"2009","unstructured":"Pagenstecher A, Stahl S, Sure U, Felbor U (2009) A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells. Hum Mol Genet 18(5):911\u2013918. https:\/\/doi.org\/10.1093\/hmg\/ddn420","journal-title":"Hum Mol Genet"},{"issue":"3","key":"4355_CR16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/jmedgenet-2019-106182","volume":"57","author":"M Rath","year":"2020","unstructured":"Rath M, Pagenstecher A, Hoischen A, Felbor U (2020) Postzygotic mosaicism in cerebral cavernous malformation. J Med Genet 57(3):212\u2013216. https:\/\/doi.org\/10.1136\/jmedgenet-2019-106182","journal-title":"J Med Genet"},{"issue":"1","key":"4355_CR17","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1038\/s41467-019-10707-x","volume":"10","author":"M Malinverno","year":"2019","unstructured":"Malinverno M, Maderna C, Abu Taha A, Corada M, Orsenigo F, Valentino M, Pisati F, Fusco C, Graziano P, Giannotta M, Yu QC, Zeng YA, Lampugnani MG, Magnusson PU, Dejana E (2019) Endothelial cell clonal expansion in the development of cerebral cavernous malformations. Nat Commun 10(1):2761. https:\/\/doi.org\/10.1038\/s41467-019-10707-x","journal-title":"Nat Commun"},{"issue":"10","key":"4355_CR18","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1161\/CIRCRESAHA.118.313970","volume":"123","author":"MR Detter","year":"2018","unstructured":"Detter MR, Snellings DA, Marchuk DA (2018) Cerebral cavernous malformations develop through clonal expansion of mutant endothelial cells. Circ Res 123(10):1143\u20131151. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313970","journal-title":"Circ Res"},{"issue":"18","key":"4355_CR19","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1158\/0008-5472.CAN-13-1079","volume":"75","author":"S Zhang","year":"2015","unstructured":"Zhang S, Zhou L, Hong B, van den Heuvel AP, Prabhu VV, Warfel NA, Kline CL, Dicker DT, Kopelovich L, El-Deiry WS (2015) Small-molecule NSC59984 restores p53 pathway signaling and antitumor effects against colorectal cancer via p73 activation and degradation of mutant p53. Cancer Res 75(18):3842\u20133852. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1079","journal-title":"Cancer Res"},{"key":"4355_CR20","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-21-0149","author":"S Zhang","year":"2022","unstructured":"Zhang S, Zhou L, El-Deiry WS (2022) Small-molecule NSC59984 induces mutant p53 degradation through a ROS-ERK2-MDM2 Axis in cancer cells. Mol Cancer Res. https:\/\/doi.org\/10.1158\/1541-7786.MCR-21-0149","journal-title":"Mol Cancer Res"},{"issue":"1","key":"4355_CR21","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41467-018-03408-4","volume":"9","author":"C Lipps","year":"2018","unstructured":"Lipps C, Klein F, Wahlicht T, Seiffert V, Butueva M, Zauers J, Truschel T, Luckner M, K\u00f6ster M, MacLeod R, Pezoldt J, H\u00fchn J, Yuan Q, M\u00fcller PP, Kempf H, Zweigerdt R, Dittrich-Breiholz O, Pufe T, Beckmann R, Drescher W, Riancho J, Sanudo C, Korff T, Opalka B, Rebmann V, G\u00f6thert JR, Alves PM, Ott M, Schucht R, Hauser H, Wirth D, May T (2018) Expansion of functional personalized cells with specific transgene combinations. Nat Commun 9(1):994. https:\/\/doi.org\/10.1038\/s41467-018-03408-4","journal-title":"Nat Commun"},{"issue":"3","key":"4355_CR22","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1111\/jcmm.14075","volume":"23","author":"K Schwefel","year":"2019","unstructured":"Schwefel K, Spiegler S, Ameling S, Much CD, Pilz RA, Otto O, V\u00f6lker U, Felbor U, Rath M (2019) Biallelic CCM3 mutations cause a clonogenic survival advantage and endothelial cell stiffening. J Cell Mol Med 23(3):1771\u20131783. https:\/\/doi.org\/10.1111\/jcmm.14075","journal-title":"J Cell Mol Med"},{"key":"4355_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-1-0716-0640-7_13","volume":"2152","author":"K Schwefel","year":"2020","unstructured":"Schwefel K, Spiegler S, Much CD, Felbor U, Rath M (2020) CRISPR\/Cas9-mediated generation of human endothelial cell knockout models of CCM disease. Methods Mol Biol 2152:169\u2013177. https:\/\/doi.org\/10.1007\/978-1-0716-0640-7_13","journal-title":"Methods Mol Biol"},{"issue":"6","key":"4355_CR24","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.stemcr.2019.05.008","volume":"12","author":"EH Neal","year":"2019","unstructured":"Neal EH, Marinelli NA, Shi Y, McClatchey PM, Balotin KM, Gullett DR, Hagerla KA, Bowman AB, Ess KC, Wikswo JP, Lippmann ES (2019) A simplified, fully defined differentiation scheme for producing blood-brain barrier endothelial cells from human iPSCs. Stem Cell Reports 12(6):1380\u20131388. https:\/\/doi.org\/10.1016\/j.stemcr.2019.05.008","journal-title":"Stem Cell Reports"},{"key":"4355_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-019-0213-z","author":"RA Wimmer","year":"2019","unstructured":"Wimmer RA, Leopoldi A, Aichinger M, Kerjaschki D, Penninger JM (2019) Generation of blood vessel organoids from human pluripotent stem cells. Nat Protoc. https:\/\/doi.org\/10.1038\/s41596-019-0213-z","journal-title":"Nat Protoc"},{"issue":"5","key":"4355_CR26","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NA Franken","year":"2006","unstructured":"Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1(5):2315\u20132319. https:\/\/doi.org\/10.1038\/nprot.2006.339","journal-title":"Nat Protoc"},{"issue":"3","key":"4355_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10456-018-9613-x","volume":"21","author":"P Nowak-Sliwinska","year":"2018","unstructured":"Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, B\u00f6ck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquiere B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW (2018) Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis 21(3):425\u2013532. https:\/\/doi.org\/10.1007\/s10456-018-9613-x","journal-title":"Angiogenesis"},{"issue":"7740","key":"4355_CR28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-018-0858-8","volume":"565","author":"RA Wimmer","year":"2019","unstructured":"Wimmer RA, Leopoldi A, Aichinger M, Wick N, Hantusch B, Novatchkova M, Taubenschmid J, H\u00e4mmerle M, Esk C, Bagley JA, Lindenhofer D, Chen G, Boehm M, Agu CA, Yang F, Fu B, Zuber J, Knoblich JA, Kerjaschki D, Penninger JM (2019) Human blood vessel organoids as a model of diabetic vasculopathy. Nature 565(7740):505\u2013510. https:\/\/doi.org\/10.1038\/s41586-018-0858-8","journal-title":"Nature"},{"issue":"5\u20136","key":"4355_CR29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1101\/gad.312561.118","volume":"32","author":"B Shan","year":"2018","unstructured":"Shan B, Pan H, Najafov A, Yuan J (2018) Necroptosis in development and diseases. Genes Dev 32(5\u20136):327\u2013340. https:\/\/doi.org\/10.1101\/gad.312561.118","journal-title":"Genes Dev"},{"issue":"10","key":"4355_CR30","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/cdd.2014.100","volume":"21","author":"C Kim","year":"2014","unstructured":"Kim C, Pasparakis M (2014) RIP kinase 3 in necroptosis: does it take two or more to kill? Cell Death Differ 21(10):1505\u20131507. https:\/\/doi.org\/10.1038\/cdd.2014.100","journal-title":"Cell Death Differ"},{"issue":"7862","key":"4355_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41586-021-03562-8","volume":"594","author":"AA Ren","year":"2021","unstructured":"Ren AA, Snellings DA, Su YS, Hong CC, Castro M, Tang AT, Detter MR, Hobson N, Girard R, Romanos S, Lightle R, Moore T, Shenkar R, Benavides C, Beaman MM, M\u00fcller-Fielitz H, Chen M, Mericko P, Yang J, Sung DC, Lawton MT, Ruppert JM, Schwaninger M, K\u00f6rbelin J, Potente M, Awad IA, Marchuk DA, Kahn ML (2021) PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism. Nature 594(7862):271\u2013276. https:\/\/doi.org\/10.1038\/s41586-021-03562-8","journal-title":"Nature"},{"issue":"9","key":"4355_CR32","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.molmed.2020.03.003","volume":"26","author":"S Abdelilah-Seyfried","year":"2020","unstructured":"Abdelilah-Seyfried S, Tournier-Lasserve E, Derry WB (2020) Blocking signalopathic events to treat cerebral cavernous malformations. Trends Mol Med 26(9):874\u2013887. https:\/\/doi.org\/10.1016\/j.molmed.2020.03.003","journal-title":"Trends Mol Med"},{"key":"4355_CR33","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/B0-12-443710-9\/00146-0","volume-title":"Encyclopedia of Biological Chemistry","author":"RL Dusek","year":"2004","unstructured":"Dusek RL, Jones JCR, Green KJ (2004) Desmosomes and Hemidesmosomes. In: Lennarz WJ, Lane MD (eds) Encyclopedia of Biological Chemistry. Elsevier, New York, pp 569\u2013576. https:\/\/doi.org\/10.1016\/B0-12-443710-9\/00146-0"},{"issue":"7","key":"4355_CR34","doi-asserted-by":"publisher","first-page":"9018","DOI":"10.1096\/fj.201902888R","volume":"34","author":"K Schwefel","year":"2020","unstructured":"Schwefel K, Spiegler S, Kirchmaier BC, Dellweg PKE, Much CD, Pane-Farre J, Strom TM, Riedel K, Felbor U, Rath M (2020) Fibronectin rescues aberrant phenotype of endothelial cells lacking either CCM1, CCM2 or CCM3. FASEB J 34(7):9018\u20139033. https:\/\/doi.org\/10.1096\/fj.201902888R","journal-title":"FASEB J"},{"issue":"11","key":"4355_CR35","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1084\/jem.20171178","volume":"214","author":"MA Lopez-Ramirez","year":"2017","unstructured":"Lopez-Ramirez MA, Fonseca G, Zeineddine HA, Girard R, Moore T, Pham A, Cao Y, Shenkar R, de Kreuk BJ, Lagarrigue F, Lawler J, Glass CK, Awad IA, Ginsberg MH (2017) Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations. J Exp Med 214(11):3331\u20133346. https:\/\/doi.org\/10.1084\/jem.20171178","journal-title":"J Exp Med"},{"issue":"2","key":"4355_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.devcel.2014.12.016","volume":"32","author":"M Renz","year":"2015","unstructured":"Renz M, Otten C, Faurobert E, Rudolph F, Zhu Y, Boulday G, Duchene J, Mickoleit M, Dietrich AC, Ramspacher C, Steed E, Manet-Dupe S, Benz A, Hassel D, Vermot J, Huisken J, Tournier-Lasserve E, Felbor U, Sure U, Albiges-Rizo C, Abdelilah-Seyfried S (2015) Regulation of beta1 integrin-Klf2-mediated angiogenesis by CCM proteins. Dev Cell 32(2):181\u2013190. https:\/\/doi.org\/10.1016\/j.devcel.2014.12.016","journal-title":"Dev Cell"},{"issue":"4","key":"4355_CR37","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1158\/0008-5472.CAN-19-1145","volume":"80","author":"S Ruan","year":"2020","unstructured":"Ruan S, Lin M, Zhu Y, Lum L, Thakur A, Jin R, Shao W, Zhang Y, Hu Y, Huang S, Hurt EM, Chang AE, Wicha MS, Li Q (2020) Integrin beta4-targeted cancer immunotherapies inhibit tumor growth and decrease metastasis. Cancer Res 80(4):771\u2013783. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-1145","journal-title":"Cancer Res"},{"issue":"12","key":"4355_CR38","doi-asserted-by":"publisher","first-page":"E2337","DOI":"10.1073\/pnas.1618298114","volume":"114","author":"B Bierie","year":"2017","unstructured":"Bierie B, Pierce SE, Kroeger C, Stover DG, Pattabiraman DR, Thiru P, Liu Donaher J, Reinhardt F, Chaffer CL, Keckesova Z, Weinberg RA (2017) Integrin-beta4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells. Proc Natl Acad Sci U S A 114(12):E2337\u2013E2346. https:\/\/doi.org\/10.1073\/pnas.1618298114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4355_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-019-1034-1","volume":"38","author":"B Ma","year":"2019","unstructured":"Ma B, Zhang L, Zou Y, He R, Wu Q, Han C, Zhang B (2019) Reciprocal regulation of integrin beta4 and KLF4 promotes gliomagenesis through maintaining cancer stem cell traits. J Exp Clin Cancer Res 38(1):23. https:\/\/doi.org\/10.1186\/s13046-019-1034-1","journal-title":"J Exp Clin Cancer Res"},{"key":"4355_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-3-030-36667-4_4","volume":"1231","author":"YS Lee","year":"2020","unstructured":"Lee YS, Cho YB (2020) CCL7 Signaling in the tumor microenvironment. Adv Exp Med Biol 1231:33\u201343. https:\/\/doi.org\/10.1007\/978-3-030-36667-4_4","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"4355_CR41","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1158\/0008-5472.CAN-11-3567","volume":"72","author":"A Tsuyada","year":"2012","unstructured":"Tsuyada A, Chow A, Wu J, Somlo G, Chu P, Loera S, Luu T, Li AX, Wu X, Ye W, Chen S, Zhou W, Yu Y, Wang YZ, Ren X, Li H, Scherle P, Kuroki Y, Wang SE (2012) CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Res 72(11):2768\u20132779. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3567","journal-title":"Cancer Res"},{"issue":"2","key":"4355_CR42","doi-asserted-by":"publisher","first-page":"571","DOI":"10.7150\/jca.47022","volume":"12","author":"S Rivas-Fuentes","year":"2021","unstructured":"Rivas-Fuentes S, Salgado-Aguayo A, Arratia-Quijada J, Gorocica-Rosete P (2021) Regulation and biological functions of the CX3CL1-CX3CR1 axis and its relevance in solid cancer: A mini-review. J Cancer 12(2):571\u2013583. https:\/\/doi.org\/10.7150\/jca.47022","journal-title":"J Cancer"},{"issue":"9","key":"4355_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003789","volume":"9","author":"M Rajaram","year":"2013","unstructured":"Rajaram M, Li J, Egeblad M, Powers RS (2013) System-wide analysis reveals a complex network of tumor-fibroblast interactions involved in tumorigenicity. PLoS Genet 9(9):e1003789. https:\/\/doi.org\/10.1371\/journal.pgen.1003789","journal-title":"PLoS Genet"},{"issue":"6","key":"4355_CR44","doi-asserted-by":"publisher","first-page":"H2836","DOI":"10.1152\/ajpheart.00113.2006","volume":"291","author":"SJ Lee","year":"2006","unstructured":"Lee SJ, Namkoong S, Kim YM, Kim CK, Lee H, Ha KS, Chung HT, Kwon YG, Kim YM (2006) Fractalkine stimulates angiogenesis by activating the Raf-1\/MEK\/ERK- and PI3K\/Akt\/eNOS-dependent signal pathways. Am J Physiol Heart Circ Physiol 291(6):H2836-2846. https:\/\/doi.org\/10.1152\/ajpheart.00113.2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"4355_CR45","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.4049\/jimmunol.165.9.5269","volume":"165","author":"CL Addison","year":"2000","unstructured":"Addison CL, Daniel TO, Burdick MD, Liu H, Ehlert JE, Xue YY, Buechi L, Walz A, Richmond A, Strieter RM (2000) The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol 165(9):5269\u20135277. https:\/\/doi.org\/10.4049\/jimmunol.165.9.5269","journal-title":"J Immunol"},{"issue":"3","key":"4355_CR46","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1182\/blood.V90.3.909","volume":"90","author":"BJ Rollins","year":"1997","unstructured":"Rollins BJ (1997) Chemokines. Blood 90(3):909\u2013928","journal-title":"Blood"},{"issue":"6","key":"4355_CR47","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cytogfr.2005.04.007","volume":"16","author":"RM Strieter","year":"2005","unstructured":"Strieter RM, Burdick MD, Gomperts BN, Belperio JA, Keane MP (2005) CXC chemokines in angiogenesis. Cytokine Growth Factor Rev 16(6):593\u2013609. https:\/\/doi.org\/10.1016\/j.cytogfr.2005.04.007","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"4355_CR48","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00018-022-04224-2","volume":"79","author":"ACY Yau","year":"2022","unstructured":"Yau ACY, Globisch MA, Onyeogaziri FC, Conze LL, Smith R, Jauhiainen S, Corada M, Orsenigo F, Huang H, Herre M, Olsson AK, Malinverno M, Sundell V, Rezai Jahromi B, Niemel\u00e4 M, Laakso A, Garlanda C, Mantovani A, Lampugnani MG, Dejana E, Magnusson PU (2022) Inflammation and neutrophil extracellular traps in cerebral cavernous malformation. Cell Mol Life Sci 79(4):206. https:\/\/doi.org\/10.1007\/s00018-022-04224-2","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"4355_CR49","doi-asserted-by":"publisher","first-page":"eaau0731","DOI":"10.1126\/sciadv.aau0731","volume":"4","author":"JP Choi","year":"2018","unstructured":"Choi JP, Wang R, Yang X, Wang X, Wang L, Ting KK, Foley M, Cogger V, Yang Z, Liu F, Han Z, Liu R, Baell J, Zheng X (2018) Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations. Sci Adv 4(11):eaau0731. https:\/\/doi.org\/10.1126\/sciadv.aau0731","journal-title":"Sci Adv"},{"issue":"3","key":"4355_CR50","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/bloodadvances.2019000268","volume":"4","author":"O Chan","year":"2020","unstructured":"Chan O, Talati C, Isenalumhe L, Shams S, Nodzon L, Fradley M, Sweet K, Pinilla-Ibarz J (2020) Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia. Blood Adv 4(3):530\u2013538. https:\/\/doi.org\/10.1182\/bloodadvances.2019000268","journal-title":"Blood Adv"},{"key":"4355_CR51","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3389\/fimmu.2019.00379","volume":"10","author":"V Mollica Poeta","year":"2019","unstructured":"Mollica Poeta V, Massara M, Capucetti A, Bonecchi R (2019) Chemokines and chemokine receptors: new targets for cancer immunotherapy. Front Immunol 10:379. https:\/\/doi.org\/10.3389\/fimmu.2019.00379","journal-title":"Front Immunol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04355-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04355-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04355-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T08:17:18Z","timestamp":1656145038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04355-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["4355"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04355-6","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"17 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MR, KS and UF are listed as inventors on a patent application (EP 21194373.3) related to the treatment or prevention of vascular malformations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study does not involve human participants or animal subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study does not involve human participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study does not involve human participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"340"}}